In order to explore the clinical relevance of Id1 depletion at the tumor microenvironment, we analyzed immune populations in tumors from mice responding to anti-PD-1 therapy (in Id1-silenced host microenvironment) and non-responding mice (mice with constitutive Id1 expression). The gene discussed is ID1; the disease is neoplasm.